AdvaMed Urges Congress to Avert Shutdown, Protect Patients

In testimony today before a key congressional subcommittee hearing, AdvaMed, the Medtech Association, called for a balance in the proposed regulations of the method used to sterilize 20 billion, or half, of all medical devices in the United States each year. The Environmental Protection Agency (EPA) is proposing restrictions of ethylene oxide (EtO) that if finalized as written, would cause severe interruptions in patient care and access to sterile medical technology. An industry analysis predicts a 30 percent to 50 percent reduction in sterilization capacity for life-saving devices and as much as 70 percent in some cases. 

Today, following a legislative hearing on improving seniors’ access to innovative medical devices and technologies, AdvaMed President and CEO Scott Whitaker commended the House Energy and Commerce Committee’s Subcommittee on Health for hosting the panel. 

Today, AdvaMed, the Medtech Association, submitted a letter to the House Committee on Oversight and Accountability regarding the Committee’s consideration of an issue that threatens to undermine the foundations of our health care system: outside financing that generates mass tort litigation over important, beneficial medical devices.

In the latest episode of the Medtech POV Podcast, AdvaMed President and CEO Scott Whitaker sits down with Dr. Peter Schneider and Dr. Justin Klein to talk about a recent New York Times story about atherectomies and peripheral artery disease (PAD) and the impact the story could have on patients seeking treatment for this condition.

Scott Whitaker, President and CEO, of AdvaMed recently had the opportunity to speak with Ambassador Kurt Volker, a distinguished diplomat who served as U.S. Ambassador to NATO and U.S. Special Representative for Ukraine. He spoke with him, along with medtech CEOs, on critical geopolitical developments and trends, the potential impact of those trends on medtech, and the need to reach civilians with critical medtech amid war and sanctions. He wanted to share some highlights from the conversation for those who missed it.

This week, AdvaMed, the Medtech Association, sent a letter to Congressional leaders regarding the proposed payment cuts to office-based specialist physicians under the Medicare Physician Fee Schedule. AdvaMed was joined on the letter to Senate Majority Leader Schumer, Senate Minority Leader McConnell, Speaker McCarthy, and House Minority Leader Jeffries by the Medical Device Manufacturers Association and the Medical Imaging and Technology Alli

Scott Whitaker, president and CEO of AdvaMed, recently chatted with Joe Mullings, chairman and CEO of The Mullings Group, about the impact of the medtech industry and the importance of connections.

Today, AdvaMed marked the one year anniversary of the signing of the bipartisan CHIPS and Science Act and called on the Biden Administration to ensure, as implementation moves forward, that the medtech industry – including their need for mature and current chips – continues to be a priority.